Dignitana
1,02
SEK
+4,62 %
DIGN
First North Stockholm
Medical Equipment & Services
Health Care
3 investorer følger denne virksomhed
+4,62%
-32%
-15%
-42,37%
-53,21%
-53%
-86,58%
-88,03%
-65,22%
dignitana.com/investor-relations
Dignitana is active in medical technology. The company's main focus is to develop, manufacture, and distribute medical aids that are primarily used as a scalp cooling system in chemotherapy treatment, where the purpose is to eliminate or greatly reduce hair loss. The company operates worldwide. Dignitana was founded in 2007 has its headquarters located in Lund.
Omsætning
86,06 mio.
EBIT %
-17,46 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
DIGN
Daglig lav / høj pris
0,97 / 1,02
SEK
Markedsværdi
82,15 mio. SEK
Aktieomsætning
8,6 t SEK
Volumen
8,5 t
Seneste videoer
Finanskalender
Årsrapport
20.02.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| Agartha AB | 29,8 % | 29,8 % |
| Swedbank Robur Microcap | 7,7 % | 7,7 % |
| Försäkringsbolaget Avanza Pension | 7,3 % | 7,3 % |
| UBS Financial Services INC | 5,2 % | 5,2 % |
| Handelsbanken Microcap Sverige | 3,8 % | 3,8 % |
| Försäkringsaktiebolaget Skandia | 3,4 % | 3,4 % |
| LQM Lundia AB | 3,3 % | 3,3 % |
| Magbaleo | 2,5 % | 2,5 % |
| Technovobis AB | 2,2 % | 2,2 % |
| FCG Fonder | 1,9 % | 1,9 % |
ViserAlle indholdstyper
Dignitana AB Publishes Q3 2024 Interim Report
Dignitana AB (publ) appoints Nomination Committee for Annual General Meeting 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools